Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Orthofix Medical (OFIX) over the last 15 years, with Q3 2025 value amounting to $12.9 million.

  • Orthofix Medical's Depreciation & Amortization (CF) fell 1471.03% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.2 million, marking a year-over-year increase of 3825.38%. This contributed to the annual value of $60.1 million for FY2024, which is 1318.81% up from last year.
  • Orthofix Medical's Depreciation & Amortization (CF) amounted to $12.9 million in Q3 2025, which was down 1471.03% from $16.9 million recorded in Q2 2025.
  • In the past 5 years, Orthofix Medical's Depreciation & Amortization (CF) registered a high of $34.4 million during Q1 2025, and its lowest value of $6.5 million during Q2 2022.
  • In the last 5 years, Orthofix Medical's Depreciation & Amortization (CF) had a median value of $12.9 million in 2025 and averaged $12.4 million.
  • In the last 5 years, Orthofix Medical's Depreciation & Amortization (CF) tumbled by 2080.84% in 2021 and then soared by 13167.14% in 2025.
  • Quarter analysis of 5 years shows Orthofix Medical's Depreciation & Amortization (CF) stood at $7.4 million in 2021, then dropped by 0.34% to $7.4 million in 2022, then soared by 88.24% to $14.0 million in 2023, then grew by 14.5% to $16.0 million in 2024, then dropped by 19.09% to $12.9 million in 2025.
  • Its Depreciation & Amortization (CF) was $12.9 million in Q3 2025, compared to $16.9 million in Q2 2025 and $34.4 million in Q1 2025.